chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 63.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Pulse pressure decreased, Respiration abnormal
Clinical narrative: Information has been received from an insurance company representative via medical records concerning a 63 (also reported as 67) year old patient with no pre-existing physician-diagnosed allergies, birth defects or medical conditions who on 19-JAN-2010, at 14:10, was administered a first dose of ZOSTAVAX (Merck) (Lot # 665293/1175Y, expiration date 14-FEB-2011) subcutaneously in the right tricep. There was no illness at time of vaccination. There were no other vaccinations within 4 weeks prior to 19-JAN-2010. Concomitant therapies included metoprolol tartrate and tramadol. It was reported that the patient passed the screening process and stated that she had not exhibited a reaction to any previous vaccinations. After vaccination she was advised that she needed to stay in the pharmacy for 15 minutes following the vaccination for observation. At approximately 14:20 (also reported as about 15 minutes later), the patient complained of dizziness/light head and weak. She was advised to sit in a chair. Over the next 5 minutes, her condition became worse. Initial assessment indicated marked anxiety, shallow/rapid respiration, and confusion without loss of consciousness, rapid/weak pulse, weakness, confusion and apprehension. Patient was placed in the shock position with legs elevated. Emergency medical services (EMS) was contacted and assistance was requested from the medical staff of the health services. In house emergency equipment was brought to the scene. Initial vitals revealed blood pressure 130/75, pulse rapid and shallow at the radial artery, carotid pulse in excess of 100 and respiratory rate of 64. At approximately 14:27, the registered nurse and others arrived on scene with an EPI PEN, adult 0.3 mg and oxygen. Oxygen was applied with mask at 4 liters per minute. Patient increased in apprehension, pulse remained rapid, and blood pressure was 109/55, respirations were rapid and shallow. The events were assumed as anaphylaxis/apparent adverse reaction to ZOSTAVAX immunization. The assessments provided by the pharmacy nurse were vasovagal not ruling out anaphylactic shock. EPI PEN was administered in anterior lateral thigh, 0.3 ml of 1:1000. Patient's symptoms improved within 4 minutes. At approximately 14:35, EMS arrived. Patient respiration was slowing, confusion and apprehension were decreasing, blood pressure was 185/95, respiratory rate was 25 and pulse was not taken. Patient was passed off to EMS. Patient was transported via ambulance to the hospital emergency room held for observation and released after 19:00 on 19-JAN-2010. Patient's practitioner was consulted and told of patient's sister's report. That had several episodes of dizziness and ashen skin pallor while shopping. The practitioner recommended that the patient make an appointment to be seen as soon as possible after release. Upon internal review, vasovagal and anaphylactic shock treated with EPI PEN were determined to be other important medical events. No further information is available. All available medical records will be provided upon request.
Age: 63.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Pulse pressure decreased, Respiratory rate increased
Clinical narrative: Information has been received from an insurance company representative via medical records concerning a 63 (also reported as 67) year old patient with no pre-existing physician-diagnosed allergies, birth defects or medical conditions who on 19-JAN-2010, at 14:10, was administered a first dose of ZOSTAVAX (Merck) (Lot # 665293/1175Y, expiration date 14-FEB-2011) subcutaneously in the right tricep. There was no illness at time of vaccination. There were no other vaccinations within 4 weeks prior to 19-JAN-2010. Concomitant therapies included metoprolol tartrate and tramadol. It was reported that the patient passed the screening process and stated that she had not exhibited a reaction to any previous vaccinations. After vaccination she was advised that she needed to stay in the pharmacy for 15 minutes following the vaccination for observation. At approximately 14:20 (also reported as about 15 minutes later), the patient complained of dizziness/light head and weak. She was advised to sit in a chair. Over the next 5 minutes, her condition became worse. Initial assessment indicated marked anxiety, shallow/rapid respiration, and confusion without loss of consciousness, rapid/weak pulse, weakness, confusion and apprehension. Patient was placed in the shock position with legs elevated. Emergency medical services (EMS) was contacted and assistance was requested from the medical staff of the health services. In house emergency equipment was brought to the scene. Initial vitals revealed blood pressure 130/75, pulse rapid and shallow at the radial artery, carotid pulse in excess of 100 and respiratory rate of 64. At approximately 14:27, the registered nurse and others arrived on scene with an EPI PEN, adult 0.3 mg and oxygen. Oxygen was applied with mask at 4 liters per minute. Patient increased in apprehension, pulse remained rapid, and blood pressure was 109/55, respirations were rapid and shallow. The events were assumed as anaphylaxis/apparent adverse reaction to ZOSTAVAX immunization. The assessments provided by the pharmacy nurse were vasovagal not ruling out anaphylactic shock. EPI PEN was administered in anterior lateral thigh, 0.3 ml of 1:1000. Patient's symptoms improved within 4 minutes. At approximately 14:35, EMS arrived. Patient respiration was slowing, confusion and apprehension were decreasing, blood pressure was 185/95, respiratory rate was 25 and pulse was not taken. Patient was passed off to EMS. Patient was transported via ambulance to the hospital emergency room held for observation and released after 19:00 on 19-JAN-2010. Patient's practitioner was consulted and told of patient's sister's report. That had several episodes of dizziness and ashen skin pallor while shopping. The practitioner recommended that the patient make an appointment to be seen as soon as possible after release. Upon internal review, vasovagal and anaphylactic shock treated with EPI PEN were determined to be other important medical events. No further information is available. All available medical records will be provided upon request.
Age: 69.0
Sex: M
Vaccine: FLU(H1N1), FLUX, FLUX(H1N1)
Symptoms: Ataxia, Balance disorder, Coordination abnormal, Guillain-Barre syndrome, Intensive care
Clinical narrative: 69 y/o M w/ PMH of DM, HTN, dylipidemia, COPD, GERD, seasonal allergies, prostate CA, s/p prostatectomy. Adm 1/12 for Guillain-Barre induced by influenza and H1N1 vaccines. On 2/2 pt started on IVIG 40 gram daily. Pt received fifth dose 2/6 at 1115. At 1225, pt de-satted and went on to respiratory distress. Pulse ox dropped from 97% to 38%. Rapid response called and pt stabilized at 1315.
Age: 69.0
Sex: M
Vaccine: FLU(H1N1), FLUX, FLUX(H1N1)
Symptoms: Muscular weakness, Plasmapheresis, Quadriparesis
Clinical narrative: 69 y/o M w/ PMH of DM, HTN, dylipidemia, COPD, GERD, seasonal allergies, prostate CA, s/p prostatectomy. Adm 1/12 for Guillain-Barre induced by influenza and H1N1 vaccines. On 2/2 pt started on IVIG 40 gram daily. Pt received fifth dose 2/6 at 1115. At 1225, pt de-satted and went on to respiratory distress. Pulse ox dropped from 97% to 38%. Rapid response called and pt stabilized at 1315.
Age: 69.0
Sex: M
Vaccine: FLU(H1N1), FLUX, FLUX(H1N1)
Symptoms: Guillain-Barre syndrome, Immunoglobulin therapy, Oxygen saturation decreased, Respiratory distress
Clinical narrative: 69 y/o M w/ PMH of DM, HTN, dylipidemia, COPD, GERD, seasonal allergies, prostate CA, s/p prostatectomy. Adm 1/12 for Guillain-Barre induced by influenza and H1N1 vaccines. On 2/2 pt started on IVIG 40 gram daily. Pt received fifth dose 2/6 at 1115. At 1225, pt de-satted and went on to respiratory distress. Pulse ox dropped from 97% to 38%. Rapid response called and pt stabilized at 1315.
Age: 16.0
Sex: F
Vaccine: HPV4, HPV4
Symptoms: Abdominal pain, Alopecia, Blood test, Body temperature increased, Depression
Clinical narrative: See enclosed office and Hematology notes. Please see notes sent on 10/29/08.
Age: 16.0
Sex: F
Vaccine: HPV4, HPV4
Symptoms: Dizziness, Fatigue, Immune system disorder, Malaise, Rash
Clinical narrative: See enclosed office and Hematology notes. Please see notes sent on 10/29/08.
Age: 16.0
Sex: F
Vaccine: HPV4, HPV4
Symptoms: Visual impairment, Vomiting
Clinical narrative: See enclosed office and Hematology notes. Please see notes sent on 10/29/08.
Age: 16.0
Sex: F
Vaccine: HPV4, HPV4
Symptoms: Laboratory test, Unevaluable event
Clinical narrative: See enclosed office and Hematology notes. Please see notes sent on 10/29/08.
Age: 34.0
Sex: F
Vaccine: MMR, TD, VARCEL, MMR, VARCEL
Symptoms: Abdominal pain, Decreased appetite, Drug exposure during pregnancy, Fatigue, Haemorrhage
Clinical narrative: Information has been received from a registered nurse for VARIVAX (Merck), a pregnancy registry product, concerning a 34 year old female patient with no drug reactions/allergies who on 02-APR-2010 was vaccinated SC with the first 0.5 ml dose of VARIVAX (Merck) (Lot# 665503/1165Y)and the first 0.5 ml dose of MMR II (Lot# 665511/1114Y). On 07-MAY-2010 the patient was vaccinated SC with the second 0.5 ml dose of VARIVAX (Merck) (Lot# 661997/1388X) and the second 0.5 ml dose of MMR II (Lot# 665511/1114Y) and was pregnant. Pregnancy that was missed when the second dose of MMR II (Merck) was given (medical error), patient did not indicate pregnancy prior to first doses of MMR II (Merck). On 07-MAY-2010 Lab data: urine pregnancy test was positive. The patient on 08-MAY-2010 experienced bleeding, abdominal pain, headache, fatigue, a loss of appetite. The patient wen to the emergency room and received fluids. The patient reported as of on 10-MAY-2010 with headache, fatigue, and could not drink or eat. Patient was told to go to the emergency room. The patient had an appointment with an unspecified obstetrician on 11-MAY-2010. The last menstruation period was 20-JAN-2010. The estimated delivery date would be 27-Oct-2010. At the time of reporting the patient's status was not recovered. Bleeding, abdominal pain, headache, fatigue, a loss of appetite were considered to be other important medical events by the reporter. Bleeding, abdominal pain, a loss of appetite, headache, fatigue, and could not drink or eat were considered to be disabling by the reporter. Additional information has been requested.
Age: 34.0
Sex: F
Vaccine: MMR, TD, VARCEL, MMR, VARCEL
Symptoms: Headache, Malaise, Skin burning sensation
Clinical narrative: Information has been received from a registered nurse for VARIVAX (Merck), a pregnancy registry product, concerning a 34 year old female patient with no drug reactions/allergies who on 02-APR-2010 was vaccinated SC with the first 0.5 ml dose of VARIVAX (Merck) (Lot# 665503/1165Y)and the first 0.5 ml dose of MMR II (Lot# 665511/1114Y). On 07-MAY-2010 the patient was vaccinated SC with the second 0.5 ml dose of VARIVAX (Merck) (Lot# 661997/1388X) and the second 0.5 ml dose of MMR II (Lot# 665511/1114Y) and was pregnant. Pregnancy that was missed when the second dose of MMR II (Merck) was given (medical error), patient did not indicate pregnancy prior to first doses of MMR II (Merck). On 07-MAY-2010 Lab data: urine pregnancy test was positive. The patient on 08-MAY-2010 experienced bleeding, abdominal pain, headache, fatigue, a loss of appetite. The patient wen to the emergency room and received fluids. The patient reported as of on 10-MAY-2010 with headache, fatigue, and could not drink or eat. Patient was told to go to the emergency room. The patient had an appointment with an unspecified obstetrician on 11-MAY-2010. The last menstruation period was 20-JAN-2010. The estimated delivery date would be 27-Oct-2010. At the time of reporting the patient's status was not recovered. Bleeding, abdominal pain, headache, fatigue, a loss of appetite were considered to be other important medical events by the reporter. Bleeding, abdominal pain, a loss of appetite, headache, fatigue, and could not drink or eat were considered to be disabling by the reporter. Additional information has been requested.
Age: 34.0
Sex: F
Vaccine: MMR, TD, VARCEL, MMR, VARCEL
Symptoms: Headache, Urine human chorionic gonadotropin positive
Clinical narrative: Information has been received from a registered nurse for VARIVAX (Merck), a pregnancy registry product, concerning a 34 year old female patient with no drug reactions/allergies who on 02-APR-2010 was vaccinated SC with the first 0.5 ml dose of VARIVAX (Merck) (Lot# 665503/1165Y)and the first 0.5 ml dose of MMR II (Lot# 665511/1114Y). On 07-MAY-2010 the patient was vaccinated SC with the second 0.5 ml dose of VARIVAX (Merck) (Lot# 661997/1388X) and the second 0.5 ml dose of MMR II (Lot# 665511/1114Y) and was pregnant. Pregnancy that was missed when the second dose of MMR II (Merck) was given (medical error), patient did not indicate pregnancy prior to first doses of MMR II (Merck). On 07-MAY-2010 Lab data: urine pregnancy test was positive. The patient on 08-MAY-2010 experienced bleeding, abdominal pain, headache, fatigue, a loss of appetite. The patient wen to the emergency room and received fluids. The patient reported as of on 10-MAY-2010 with headache, fatigue, and could not drink or eat. Patient was told to go to the emergency room. The patient had an appointment with an unspecified obstetrician on 11-MAY-2010. The last menstruation period was 20-JAN-2010. The estimated delivery date would be 27-Oct-2010. At the time of reporting the patient's status was not recovered. Bleeding, abdominal pain, headache, fatigue, a loss of appetite were considered to be other important medical events by the reporter. Bleeding, abdominal pain, a loss of appetite, headache, fatigue, and could not drink or eat were considered to be disabling by the reporter. Additional information has been requested.
Age: 3.0
Sex: M
Vaccine: DTAP, PNC13
Symptoms: Abnormal behaviour, Crying, Inappropriate schedule of drug administration, Mood altered, Pyrexia
Clinical narrative: Patient was given an additional DTaP in error on 4-28-2010.  I notified his mother immediately at clinic of the error and followed up with her on 4-29-2010.  At that time she reported that other than a low grade fever he was fine.  I called on 5-4-2010 to follow up and left a message.  On 5-13-2010 mother called to report that 1-2 days after he received his vaccinations his mood changed.  She states that he would drop to the floor and scream, cry for no reason and just become very upset which is not his usual nature.  She could not recall the exact date and time when  this started.  I called on 5-17-2010 to continue to follow up but no one was at home.  I will call again later.  Mother has notified their family doctor as well. I encouraged her to continue to monitor the patient's behavior and notify facility and patient's doctor of any changes or updates.
Age: 3.0
Sex: M
Vaccine: DTAP, PNC13
Symptoms: Screaming, Vaccination error
Clinical narrative: Patient was given an additional DTaP in error on 4-28-2010.  I notified his mother immediately at clinic of the error and followed up with her on 4-29-2010.  At that time she reported that other than a low grade fever he was fine.  I called on 5-4-2010 to follow up and left a message.  On 5-13-2010 mother called to report that 1-2 days after he received his vaccinations his mood changed.  She states that he would drop to the floor and scream, cry for no reason and just become very upset which is not his usual nature.  She could not recall the exact date and time when  this started.  I called on 5-17-2010 to continue to follow up but no one was at home.  I will call again later.  Mother has notified their family doctor as well. I encouraged her to continue to monitor the patient's behavior and notify facility and patient's doctor of any changes or updates.
Sex: M
Vaccine: PPV
Symptoms: Spleen disorder, Vaccination complication
Clinical narrative: Information has been received from Pfizer and was assigned manufacturer report number 2010056103. A male consumer was vaccinated with a dose of PNEUMOVAX on an unknown date. The consumer had a bad reaction to PNEUMOVAX. The patient had lost his spleen and needed yearly vaccines. It was unknown if the patient sought medical attention. At the time of the report, the patient's status was unknown. Upon internal review, lost his spleen was determined to be an other important medical event. This was originally reported by a consumer to a sales representative. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Injection site erythema, Injection site induration, Injection site mass, Injection site swelling, Injection site vesicles
Clinical narrative: Information has been received from a nurse practitioner concerning a patient "between 1 and 4 years old" who was vaccinated on an unspecified date "between March and April 2010", with a dose of MMR II (Lot # 664659/0838Y) into the left thigh. The nurse reported that the patient had reactions at the injection site. The patient had a hard red and raised bump and blisters around the site as well. The patient required hospitalization for 2 days and surgery was considered, however not performed. At the time of this report, the patient had recovered on an unspecified date. This is one of several reports received from the same source. A lot check has been initiated. Additional information has been requested.
Age: 1.1
Sex: M
Vaccine: HEPA, MMR, PNC13, VARCEL
Symptoms: Vomiting
Clinical narrative: MOM CALLED TO STATE THAT PT HAS BEEN CONSTANTLY THROWING UP SINCE 6 PM LAST EVENING.
Age: 62.0
Sex: F
Vaccine: FLU(H1N1), FLU3
Symptoms: Diplopia, Dizziness, Gait disturbance, Miller Fisher syndrome, Paraesthesia
Clinical narrative: Possible Guillain-Barre with Miller Fisher variant- paresthesia, double vision, dizziness, unsteady gait.
Age: 68.0
Sex: M
Vaccine: VARZOS
Symptoms: Herpes zoster, Skin lesion
Clinical narrative: New onset shingles. He had recived the vac 2009.
Age: 15.0
Sex: F
Vaccine: HPV4
Symptoms: Blood pressure decreased, Body temperature increased, Diarrhoea, Dizziness, Dyskinesia
Clinical narrative: Information has been received from a physician, a medical assistant and the patient's mother concerning, a 15 year old female with no medical history or drug reaction/allergies reported who on 19-APR-2010 was vaccinated with a dose of GARDASIL (lot n. 663573/0969Y), 0.5 mg.  Concomitant therapy included LOESTRIN.  The patient's mother stated that her daughter was given GARDASIL on 19-APR-2010, and this date, she "jerked" within 20 seconds and then she passed out and her blood pressure dropped precipitously.  She came to and had nausea and tenderness at the injection site.  She started feeling dizzy and had a 102 degree fever for 4 hours.  Her extremities started tingling and she had diarrhea on days 3 and 4 following injection, and she had fatigue for first 72 hours.  At the time of reporting, the patient still had bouts with dizziness and nausea and she passed out again on 03-MAY-2010.  On 04-MAY-2010, the patient experienced headache.  Subsequently, the physician stated that the patient received the first dose of GARDASIL and experienced syncope with seizure like movement of the arms and legs about 15 seconds.  Physician felt as though it is related to GARDASIL.  Later, the medical assistant reported that the patient experienced syncope then, tonic clonic movements.  She stated that the physician did not feel this was a seizure (conflicting information with physician's information).  The event was not disabling or life threatening and patient did not need to go to the emergency room.  Treatment included an antiemetic and increased fluid intake.  At the time of reporting the patient was still recovering.  Upon internal review syncope with seizure like movement of the arms and legs was considered to be an other important medical event.  Additional information has been requested.
Age: 15.0
Sex: F
Vaccine: HPV4
Symptoms: Fatigue, Headache, Injection site pain, Loss of consciousness, Nausea
Clinical narrative: Information has been received from a physician, a medical assistant and the patient's mother concerning, a 15 year old female with no medical history or drug reaction/allergies reported who on 19-APR-2010 was vaccinated with a dose of GARDASIL (lot n. 663573/0969Y), 0.5 mg.  Concomitant therapy included LOESTRIN.  The patient's mother stated that her daughter was given GARDASIL on 19-APR-2010, and this date, she "jerked" within 20 seconds and then she passed out and her blood pressure dropped precipitously.  She came to and had nausea and tenderness at the injection site.  She started feeling dizzy and had a 102 degree fever for 4 hours.  Her extremities started tingling and she had diarrhea on days 3 and 4 following injection, and she had fatigue for first 72 hours.  At the time of reporting, the patient still had bouts with dizziness and nausea and she passed out again on 03-MAY-2010.  On 04-MAY-2010, the patient experienced headache.  Subsequently, the physician stated that the patient received the first dose of GARDASIL and experienced syncope with seizure like movement of the arms and legs about 15 seconds.  Physician felt as though it is related to GARDASIL.  Later, the medical assistant reported that the patient experienced syncope then, tonic clonic movements.  She stated that the physician did not feel this was a seizure (conflicting information with physician's information).  The event was not disabling or life threatening and patient did not need to go to the emergency room.  Treatment included an antiemetic and increased fluid intake.  At the time of reporting the patient was still recovering.  Upon internal review syncope with seizure like movement of the arms and legs was considered to be an other important medical event.  Additional information has been requested.
Age: 15.0
Sex: F
Vaccine: HPV4
Symptoms: Paraesthesia, Pyrexia, Reaction to previous exposure to any vaccine
Clinical narrative: Information has been received from a physician, a medical assistant and the patient's mother concerning, a 15 year old female with no medical history or drug reaction/allergies reported who on 19-APR-2010 was vaccinated with a dose of GARDASIL (lot n. 663573/0969Y), 0.5 mg.  Concomitant therapy included LOESTRIN.  The patient's mother stated that her daughter was given GARDASIL on 19-APR-2010, and this date, she "jerked" within 20 seconds and then she passed out and her blood pressure dropped precipitously.  She came to and had nausea and tenderness at the injection site.  She started feeling dizzy and had a 102 degree fever for 4 hours.  Her extremities started tingling and she had diarrhea on days 3 and 4 following injection, and she had fatigue for first 72 hours.  At the time of reporting, the patient still had bouts with dizziness and nausea and she passed out again on 03-MAY-2010.  On 04-MAY-2010, the patient experienced headache.  Subsequently, the physician stated that the patient received the first dose of GARDASIL and experienced syncope with seizure like movement of the arms and legs about 15 seconds.  Physician felt as though it is related to GARDASIL.  Later, the medical assistant reported that the patient experienced syncope then, tonic clonic movements.  She stated that the physician did not feel this was a seizure (conflicting information with physician's information).  The event was not disabling or life threatening and patient did not need to go to the emergency room.  Treatment included an antiemetic and increased fluid intake.  At the time of reporting the patient was still recovering.  Upon internal review syncope with seizure like movement of the arms and legs was considered to be an other important medical event.  Additional information has been requested.
Age: 9.0
Sex: M
Vaccine: FLU(H1N1), FLU3, HEPA, VARCEL
Symptoms: Back pain, Crying, Headache, Hypersomnia, Muscle spasms
Clinical narrative: Patient's mother reports between 1 and 2 hours after leaving clinic on Friday 5/14/2010 patient developed headache > backache > arm and leg pain> generalized body pain> cramping of hands.  Crying with pain and fingers on hands curled up.  Unable to straighten fingers on own for ~5- 10 minutes.  Mother able to straighten fingers passively.  Given Motrin and symptoms completely resolved 20 minutes after taking.   Slept more than usual over weekend including a 4 hour nap on Sunday.
Age: 9.0
Sex: M
Vaccine: FLU(H1N1), FLU3, HEPA, VARCEL
Symptoms: Musculoskeletal stiffness, Pain
Clinical narrative: Patient's mother reports between 1 and 2 hours after leaving clinic on Friday 5/14/2010 patient developed headache > backache > arm and leg pain> generalized body pain> cramping of hands.  Crying with pain and fingers on hands curled up.  Unable to straighten fingers on own for ~5- 10 minutes.  Mother able to straighten fingers passively.  Given Motrin and symptoms completely resolved 20 minutes after taking.   Slept more than usual over weekend including a 4 hour nap on Sunday.
Age: 11.0
Sex: F
Vaccine: TDAP, VARCEL
Symptoms: Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Area to LD where Tdap given was reported to be red and "a little puffy".  Redness was reported by Father to be 3 1/2 to 4" oval area to site that was also sore.  Mom took child to MD on 5/13 for assessment.
Age: 11.0
Sex: M
Vaccine: HPV4, MNQ, TDAP, VARCEL
Symptoms: Injection site erythema, Injection site rash, Rash erythematous
Clinical narrative: Fine red raised rash at site of injection - L deltoid. Rash spread up to shoulder.  MD perscribed cortisone cream to affected area.
Age: 30.0
Sex: F
Vaccine: VARCEL
Symptoms: Headache, Injection site reaction, Pruritus, Scab, Skin lesion
Clinical narrative: Out break at site of injection, patient reported noticing on weekend, seen in office by nurse (nurse visit) doctor did (5/3) also examine. Patient instructed to use CALAMINE for itch, stay out of sun. Already on ALLEGRA for allergies. Spoke w/patient again 5/6 several lesions now on back, chest and other arm. Original ones are crusted over. No fever. Reported mild headaches only.
Age: 15.0
Sex: F
Vaccine: HPV4, VARCEL, HPV4
Symptoms: Erythema, Induration, Skin warm
Clinical narrative: Got a huge baseball size hard red hot spot on her arm. Was very sore. No fever. Lasted started Thursday night, worse Friday and over the weekend. Lasted approximately 5 days, warm compresses.
Age: 15.0
Sex: F
Vaccine: HPV4, VARCEL, HPV4
Symptoms: Erythema, Oedema peripheral, Pain in extremity
Clinical narrative: Got a huge baseball size hard red hot spot on her arm. Was very sore. No fever. Lasted started Thursday night, worse Friday and over the weekend. Lasted approximately 5 days, warm compresses.
Age: 13.0
Sex: F
Vaccine: FLU(H1N1), HPV4, VARCEL
Symptoms: Body temperature increased
Clinical narrative: Mother stated that "last night my daughter had a lot of temperature, and now it is 101.5"  Denies N/V.  Advised to give fever reducing meds, increase H2O.
Age: 35.0
Sex: F
Vaccine: FLUN(H1N1)
Symptoms: CSF glucose normal, CSF protein normal, CSF white blood cell count increased, Central nervous system lesion, Computerised tomogram normal
Clinical narrative: The patient is a 35 year old female recently hospitalized with speech difficulties correlated with abnormal MRI findings. She was discharged on April 3, 2010 and is following up as an outpatient today. Earlier today she has seen her ophthalmologist and had an eye exam, which was normal. The patient was in her usual state of health until to weeks prior to her presentation to the hospital on April 2, 2010 when she noticed difficulty with language. She described trouble getting her words out, but knew what she wanted to say. This coincided with the onset of her last menstruation which lasted four days. The symptoms continued, getting worse especially in the afternoon. In addition, she had a slurred speech and some posterior headaches over two days prior to presentation. Her primary physician ordered a brain MRI, which showed multiple ring enhancing lesions. She had a CT of the chest, abdomen, and pelvis which did not show any obvious malignancies and so she was transferred to medical center for further evaluation. On April 2, 2010 the doctor as an inpatient and did a lumbar puncture which showed a slightly elevated WBC of 9 with lymphocytic predominance of 92%, protein 33, glucose 65. Infectious workup are negative so far. Some of the tests are still pending including cytology of the CSF. The differential diagnosis included CNS lymphoma, demyelinating diseases, or an infection. Since her discharge the patient has been stable. She continues to experience difficulty with speech exacerbated by stress and lack of sleep, otherwise she has no neurological findings and no new complaints. She did have a little bit headache after the lumbar puncture. It seems to be worse at night and relieved with p.r.n Tylenol.
Age: 35.0
Sex: F
Vaccine: FLUN(H1N1)
Symptoms: Cytology, Dysarthria, Headache, Insomnia, Lumbar puncture abnormal
Clinical narrative: The patient is a 35 year old female recently hospitalized with speech difficulties correlated with abnormal MRI findings. She was discharged on April 3, 2010 and is following up as an outpatient today. Earlier today she has seen her ophthalmologist and had an eye exam, which was normal. The patient was in her usual state of health until to weeks prior to her presentation to the hospital on April 2, 2010 when she noticed difficulty with language. She described trouble getting her words out, but knew what she wanted to say. This coincided with the onset of her last menstruation which lasted four days. The symptoms continued, getting worse especially in the afternoon. In addition, she had a slurred speech and some posterior headaches over two days prior to presentation. Her primary physician ordered a brain MRI, which showed multiple ring enhancing lesions. She had a CT of the chest, abdomen, and pelvis which did not show any obvious malignancies and so she was transferred to medical center for further evaluation. On April 2, 2010 the doctor as an inpatient and did a lumbar puncture which showed a slightly elevated WBC of 9 with lymphocytic predominance of 92%, protein 33, glucose 65. Infectious workup are negative so far. Some of the tests are still pending including cytology of the CSF. The differential diagnosis included CNS lymphoma, demyelinating diseases, or an infection. Since her discharge the patient has been stable. She continues to experience difficulty with speech exacerbated by stress and lack of sleep, otherwise she has no neurological findings and no new complaints. She did have a little bit headache after the lumbar puncture. It seems to be worse at night and relieved with p.r.n Tylenol.
Age: 35.0
Sex: F
Vaccine: FLUN(H1N1)
Symptoms: Lymphocyte percentage increased, Nuclear magnetic resonance imaging brain abnormal, Skin lesion, Speech disorder, Stress
Clinical narrative: The patient is a 35 year old female recently hospitalized with speech difficulties correlated with abnormal MRI findings. She was discharged on April 3, 2010 and is following up as an outpatient today. Earlier today she has seen her ophthalmologist and had an eye exam, which was normal. The patient was in her usual state of health until to weeks prior to her presentation to the hospital on April 2, 2010 when she noticed difficulty with language. She described trouble getting her words out, but knew what she wanted to say. This coincided with the onset of her last menstruation which lasted four days. The symptoms continued, getting worse especially in the afternoon. In addition, she had a slurred speech and some posterior headaches over two days prior to presentation. Her primary physician ordered a brain MRI, which showed multiple ring enhancing lesions. She had a CT of the chest, abdomen, and pelvis which did not show any obvious malignancies and so she was transferred to medical center for further evaluation. On April 2, 2010 the doctor as an inpatient and did a lumbar puncture which showed a slightly elevated WBC of 9 with lymphocytic predominance of 92%, protein 33, glucose 65. Infectious workup are negative so far. Some of the tests are still pending including cytology of the CSF. The differential diagnosis included CNS lymphoma, demyelinating diseases, or an infection. Since her discharge the patient has been stable. She continues to experience difficulty with speech exacerbated by stress and lack of sleep, otherwise she has no neurological findings and no new complaints. She did have a little bit headache after the lumbar puncture. It seems to be worse at night and relieved with p.r.n Tylenol.
Age: 2.0
Sex: F
Vaccine: PNC13
Symptoms: Vomiting
Clinical narrative: Vomited in car several times on way home from appt after receiving vaccines.  Had been well prior to appt.
Age: 5.0
Sex: F
Vaccine: DTAPHEPBIP, MMR, VARCEL
Symptoms: Injection site erythema, Injection site haematoma, Injection site induration, Injection site pruritus, Injection site swelling
Clinical narrative: 5-6-10  Mother called to report - 1st noticed red area.  5/4/10 - gradually increased in size to 4 " diam, raised, hard & hot to touch - on right thigh (front) at injection site.  Sl itching at site.  Given antihistamine.  5-7-10 Swelling is down.  Injection site - normal size -> only some bruising remains.
Age: 5.0
Sex: F
Vaccine: DTAPHEPBIP, MMR, VARCEL
Symptoms: Injection site warmth
Clinical narrative: 5-6-10  Mother called to report - 1st noticed red area.  5/4/10 - gradually increased in size to 4 " diam, raised, hard & hot to touch - on right thigh (front) at injection site.  Sl itching at site.  Given antihistamine.  5-7-10 Swelling is down.  Injection site - normal size -> only some bruising remains.
Age: 1.51
Sex: M
Vaccine: DTAPIPVHIB, HEP, PNC
Symptoms: Febrile convulsion
Clinical narrative: Febrile seizure 2/18/10 3:15 P.
Age: 22.0
Sex: F
Vaccine: HEP
Symptoms: Cold sweat, Dizziness, Hyperhidrosis, Nausea, Pyrexia
Clinical narrative: Approx 2 hrs after immunization, Pt felt dizzy and lightheaded.  Later that night, she experienced nausea, sweaty and clammy, and a fever of 101.2 degrees F.  After a good nights rest, she felt a lot better.  No further effects noted.
Age: 1.05
Sex: F
Vaccine: HEPA, HIBV, MMR, PNC13, VARCEL
Symptoms: Pyrexia, Rash papular
Clinical narrative: On 04-27-10 (PM) developed fever which persisted higher through 4-29-10 and accompanied by a fine papular rash to forearms and lower legs and a few papules on her face, and back.  Fever 103.6 ax. max from 4-27 PM - 5-2-10.  Used TYLENOL - Alt with IBUPROFEN.
Age: 62.0
Sex: M
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: Herpes zoster.
Age: 5.0
Sex: M
Vaccine: MMR, VARCEL
Symptoms: Injection site erythema, Injection site induration, Injection site swelling, Injection site warmth
Clinical narrative: Developed left upper arm swelling at injection (VARIVAX) site less than 18 hrs after receiving immunization; warm, firm, swollen and red: Benadryl and MOTRIN prn; ice/cool compresses to site as tolerated.
Age: 4.0
Sex: M
Vaccine: DTAP, IPV, PNC13
Symptoms: Erythema, Pruritus, Swelling
Clinical narrative: Redness, swelling, itchy
Age: 0.46
Sex: M
Vaccine: DTAPIPVHIB, HEP, PNC13, RV5
Symptoms: Rash generalised
Clinical narrative: Red rash start on face, and then spread to the entire body. Child was not fussy, no fever, no loss of appetite. No signs of discomfort or distress. Did not report to Health department until 11:00 a.m. on 5/17/2010. Did not seek medical care over the weekend. Mom has been giving Tylenol.
Age: 1.82
Sex: M
Vaccine: FLU3, PNC13
Symptoms: Feeling abnormal, Unresponsive to stimuli
Clinical narrative: Father stated that child seemed "not himself". Child was not focusing on things and would not respond to his name for about one hour.
Age: 0.31
Sex: M
Vaccine: DTAPIPVHIB, HEP, PNC13
Symptoms: Death, Respiratory arrest
Clinical narrative: According to parents the baby was found not breathing in bed. Taken to ER. Died before reaching the ER.
Age: 1.01
Sex: M
Vaccine: HEPA, MMR, VARCEL
Symptoms: Pyrexia, Rash
Clinical narrative: Fever on day 5 and 6 after vaccine administered.  Rash appeared on day 8 (05/11/2010), on back, chest, face.  The rash lasted for 4 days.
Age: 2.0
Sex: F
Vaccine: HIBV
Symptoms: Injection site erythema, Injection site induration, Pyrexia, Skin warm
Clinical narrative: KNOT, HOT TO TOUCH, FEVER, REDNESS
Age: 3.0
Sex: M
Vaccine: HEPA
Symptoms: Erythema, Skin warm
Clinical narrative: REDNESS, HOT TO TOUCH
Age: 20.0
Sex: F
Vaccine: ANTH
Symptoms: Activities of daily living impaired, Alopecia, Arthralgia, Bed rest, Blindness
Clinical narrative: June through July 2007: Symptom onset following receipt of anthrax vaccines which persisted for several weeks. Did not seek evaluation. Felt extremely tired, with bouts of generalized aching pain of muscles and joints, nausea and vomiting, fevers, felt hot alternating with chills, hair started falling out, and noted delayed healing time. After these episodes, noted increased frequency of infections and then noted onset of sores, including sores in her mouth. February 2008: Felt uncomfortable, with some joint and muscle pain, as well as noted fevers and malaise. June 2008: Acute onset episode preceded by feeling overheated alternating with chills and N/V/D, with severe chest pain and palpitations associated with loss of vision and reported heart rate in the 30s. Following episode SM complained of profound fatigue, joint and muscle pain, paresthesias, ongoing chest pain and dyspnea. headaches, problems concentrating, and irregular menstrual cycles. Symptoms improved slightly, but her health never returned to baseline. Between Sep 2008 and June 2009, SM "pushed through" her duties and did not seek medical evaluations. - June 2009: Acute episode of chest pain preceded by N/V and hot/cold intolerance and chills. Presented with intense but vague chest discomfort and shortness of breath with associated loss of vision. Admitted to rule out MI. Following discharge, SM experienced profound fatigue requiring 4 weeks of bedrest, sleeping 10-18 hours per day. She continued to experience multi-system symptom complex, with predominant symptom being fatigue. Not able to make it through an 8-hour day without napping, continues to require periods of bed rest and increased sleep, particularly after any physical activity. Began an extensive medical evaluation after admission in June.
Age: 20.0
Sex: F
Vaccine: ANTH
Symptoms: Chest pain, Chills, Diarrhoea, Discomfort, Disturbance in attention
Clinical narrative: June through July 2007: Symptom onset following receipt of anthrax vaccines which persisted for several weeks. Did not seek evaluation. Felt extremely tired, with bouts of generalized aching pain of muscles and joints, nausea and vomiting, fevers, felt hot alternating with chills, hair started falling out, and noted delayed healing time. After these episodes, noted increased frequency of infections and then noted onset of sores, including sores in her mouth. February 2008: Felt uncomfortable, with some joint and muscle pain, as well as noted fevers and malaise. June 2008: Acute onset episode preceded by feeling overheated alternating with chills and N/V/D, with severe chest pain and palpitations associated with loss of vision and reported heart rate in the 30s. Following episode SM complained of profound fatigue, joint and muscle pain, paresthesias, ongoing chest pain and dyspnea. headaches, problems concentrating, and irregular menstrual cycles. Symptoms improved slightly, but her health never returned to baseline. Between Sep 2008 and June 2009, SM "pushed through" her duties and did not seek medical evaluations. - June 2009: Acute episode of chest pain preceded by N/V and hot/cold intolerance and chills. Presented with intense but vague chest discomfort and shortness of breath with associated loss of vision. Admitted to rule out MI. Following discharge, SM experienced profound fatigue requiring 4 weeks of bedrest, sleeping 10-18 hours per day. She continued to experience multi-system symptom complex, with predominant symptom being fatigue. Not able to make it through an 8-hour day without napping, continues to require periods of bed rest and increased sleep, particularly after any physical activity. Began an extensive medical evaluation after admission in June.
Age: 20.0
Sex: F
Vaccine: ANTH
Symptoms: Dyspnoea, Fatigue, Feeling hot, Headache, Heart rate decreased
Clinical narrative: June through July 2007: Symptom onset following receipt of anthrax vaccines which persisted for several weeks. Did not seek evaluation. Felt extremely tired, with bouts of generalized aching pain of muscles and joints, nausea and vomiting, fevers, felt hot alternating with chills, hair started falling out, and noted delayed healing time. After these episodes, noted increased frequency of infections and then noted onset of sores, including sores in her mouth. February 2008: Felt uncomfortable, with some joint and muscle pain, as well as noted fevers and malaise. June 2008: Acute onset episode preceded by feeling overheated alternating with chills and N/V/D, with severe chest pain and palpitations associated with loss of vision and reported heart rate in the 30s. Following episode SM complained of profound fatigue, joint and muscle pain, paresthesias, ongoing chest pain and dyspnea. headaches, problems concentrating, and irregular menstrual cycles. Symptoms improved slightly, but her health never returned to baseline. Between Sep 2008 and June 2009, SM "pushed through" her duties and did not seek medical evaluations. - June 2009: Acute episode of chest pain preceded by N/V and hot/cold intolerance and chills. Presented with intense but vague chest discomfort and shortness of breath with associated loss of vision. Admitted to rule out MI. Following discharge, SM experienced profound fatigue requiring 4 weeks of bedrest, sleeping 10-18 hours per day. She continued to experience multi-system symptom complex, with predominant symptom being fatigue. Not able to make it through an 8-hour day without napping, continues to require periods of bed rest and increased sleep, particularly after any physical activity. Began an extensive medical evaluation after admission in June.
Age: 20.0
Sex: F
Vaccine: ANTH
Symptoms: Hypersomnia, Impaired healing, Infection, Malaise, Menstruation irregular
Clinical narrative: June through July 2007: Symptom onset following receipt of anthrax vaccines which persisted for several weeks. Did not seek evaluation. Felt extremely tired, with bouts of generalized aching pain of muscles and joints, nausea and vomiting, fevers, felt hot alternating with chills, hair started falling out, and noted delayed healing time. After these episodes, noted increased frequency of infections and then noted onset of sores, including sores in her mouth. February 2008: Felt uncomfortable, with some joint and muscle pain, as well as noted fevers and malaise. June 2008: Acute onset episode preceded by feeling overheated alternating with chills and N/V/D, with severe chest pain and palpitations associated with loss of vision and reported heart rate in the 30s. Following episode SM complained of profound fatigue, joint and muscle pain, paresthesias, ongoing chest pain and dyspnea. headaches, problems concentrating, and irregular menstrual cycles. Symptoms improved slightly, but her health never returned to baseline. Between Sep 2008 and June 2009, SM "pushed through" her duties and did not seek medical evaluations. - June 2009: Acute episode of chest pain preceded by N/V and hot/cold intolerance and chills. Presented with intense but vague chest discomfort and shortness of breath with associated loss of vision. Admitted to rule out MI. Following discharge, SM experienced profound fatigue requiring 4 weeks of bedrest, sleeping 10-18 hours per day. She continued to experience multi-system symptom complex, with predominant symptom being fatigue. Not able to make it through an 8-hour day without napping, continues to require periods of bed rest and increased sleep, particularly after any physical activity. Began an extensive medical evaluation after admission in June.
Age: 20.0
Sex: F
Vaccine: ANTH
Symptoms: Myalgia, Nausea, Pain, Palpitations, Paraesthesia
Clinical narrative: June through July 2007: Symptom onset following receipt of anthrax vaccines which persisted for several weeks. Did not seek evaluation. Felt extremely tired, with bouts of generalized aching pain of muscles and joints, nausea and vomiting, fevers, felt hot alternating with chills, hair started falling out, and noted delayed healing time. After these episodes, noted increased frequency of infections and then noted onset of sores, including sores in her mouth. February 2008: Felt uncomfortable, with some joint and muscle pain, as well as noted fevers and malaise. June 2008: Acute onset episode preceded by feeling overheated alternating with chills and N/V/D, with severe chest pain and palpitations associated with loss of vision and reported heart rate in the 30s. Following episode SM complained of profound fatigue, joint and muscle pain, paresthesias, ongoing chest pain and dyspnea. headaches, problems concentrating, and irregular menstrual cycles. Symptoms improved slightly, but her health never returned to baseline. Between Sep 2008 and June 2009, SM "pushed through" her duties and did not seek medical evaluations. - June 2009: Acute episode of chest pain preceded by N/V and hot/cold intolerance and chills. Presented with intense but vague chest discomfort and shortness of breath with associated loss of vision. Admitted to rule out MI. Following discharge, SM experienced profound fatigue requiring 4 weeks of bedrest, sleeping 10-18 hours per day. She continued to experience multi-system symptom complex, with predominant symptom being fatigue. Not able to make it through an 8-hour day without napping, continues to require periods of bed rest and increased sleep, particularly after any physical activity. Began an extensive medical evaluation after admission in June.
Age: 20.0
Sex: F
Vaccine: ANTH
Symptoms: Pyrexia, Stomatitis, Temperature intolerance, Vomiting
Clinical narrative: June through July 2007: Symptom onset following receipt of anthrax vaccines which persisted for several weeks. Did not seek evaluation. Felt extremely tired, with bouts of generalized aching pain of muscles and joints, nausea and vomiting, fevers, felt hot alternating with chills, hair started falling out, and noted delayed healing time. After these episodes, noted increased frequency of infections and then noted onset of sores, including sores in her mouth. February 2008: Felt uncomfortable, with some joint and muscle pain, as well as noted fevers and malaise. June 2008: Acute onset episode preceded by feeling overheated alternating with chills and N/V/D, with severe chest pain and palpitations associated with loss of vision and reported heart rate in the 30s. Following episode SM complained of profound fatigue, joint and muscle pain, paresthesias, ongoing chest pain and dyspnea. headaches, problems concentrating, and irregular menstrual cycles. Symptoms improved slightly, but her health never returned to baseline. Between Sep 2008 and June 2009, SM "pushed through" her duties and did not seek medical evaluations. - June 2009: Acute episode of chest pain preceded by N/V and hot/cold intolerance and chills. Presented with intense but vague chest discomfort and shortness of breath with associated loss of vision. Admitted to rule out MI. Following discharge, SM experienced profound fatigue requiring 4 weeks of bedrest, sleeping 10-18 hours per day. She continued to experience multi-system symptom complex, with predominant symptom being fatigue. Not able to make it through an 8-hour day without napping, continues to require periods of bed rest and increased sleep, particularly after any physical activity. Began an extensive medical evaluation after admission in June.